Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000050

COFO and Secretary sold 15,162 shares at an average $20.33 ($308,291)

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COFO and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-06 Sale : show line 1 in the form −12,255 $20.22 $247,796 247,215 D
2025-01-07 Sale : show line 2 in the form −2,907 $20.81 $60,495 244,308 D
Open-market sales · 15,162 sh · avg $20.33 · $308,291
Loading xslF345X05/wk-form4_1736385937.xml…